Globus Medical, Inc. (GMED)
NYSE: GMED · IEX Real-Time Price · USD
53.92
+0.85 (1.61%)
Mar 28, 2024, 1:36 PM EDT - Market open

Globus Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2009
Revenue
1,5681,023958.1789.04785.37712.97635.98563.99544.75474.37
Upgrade
Revenue Growth (YoY)
53.34%6.76%21.43%0.47%10.15%12.11%12.76%3.53%14.84%9.19%
Upgrade
Cost of Revenue
548.17263.73239.22217.46179.98159.41150.45134.71132.33110.77
Upgrade
Gross Profit
1,020759.12718.88571.58605.39553.56485.52429.29412.42363.6
Upgrade
Selling, General & Admin
643.41432.12408.15354.76354.76311.59267.82222.16210.24188.63
Upgrade
Research & Development
124.0173.0297.3584.5260.0755.543.6844.5336.3131.17
Upgrade
Other Operating Expenses
119.7426.0441.4320.8718.5717.1512.198.46-6.365.44
Upgrade
Operating Expenses
887.16531.17546.93460.15433.4384.23323.68275.15240.2225.24
Upgrade
Operating Income
133.14227.95171.95111.43171.99169.33161.84154.14172.22138.36
Upgrade
Interest Expense / Income
-20.13-14.23-9.3-13.95-17.41-13.28-6.61-3.0600
Upgrade
Other Expense / Income
-12.12-0.840.84-0.51-0.55-6-1.48-0.08-0.58-0.28
Upgrade
Pretax Income
165.39243.02180.41125.9189.95188.61169.93157.28172.81138.64
Upgrade
Income Tax
42.5252.8531.2223.6134.7432.1362.5852.9460.0246.16
Upgrade
Net Income
122.87190.17149.19102.29155.21156.47107.35104.34112.7892.49
Upgrade
Net Income Growth
-35.39%27.47%45.86%-34.10%-0.81%45.76%2.88%-7.49%21.95%34.79%
Upgrade
Shares Outstanding (Basic)
11310010199999896969594
Upgrade
Shares Outstanding (Diluted)
11510310410110210198969695
Upgrade
Shares Change
11.68%-0.95%2.63%-1.01%0.67%3.50%1.51%0.37%0.65%1.34%
Upgrade
EPS (Basic)
1.091.891.481.041.571.601.121.091.190.98
Upgrade
EPS (Diluted)
1.071.851.441.011.521.541.101.081.170.97
Upgrade
EPS Growth
-42.16%28.47%42.57%-33.55%-1.30%40.00%1.85%-7.69%20.62%32.88%
Upgrade
Free Cash Flow
165.23104.42219.38135.14101.23126.95107.76106.9173.2554.42
Upgrade
Free Cash Flow Per Share
1.461.042.181.371.021.301.121.120.770.58
Upgrade
Gross Margin
65.05%74.22%75.03%72.44%77.08%77.64%76.34%76.12%75.71%76.65%
Upgrade
Operating Margin
8.49%22.29%17.95%14.12%21.90%23.75%25.45%27.33%31.61%29.17%
Upgrade
Profit Margin
7.83%18.59%15.57%12.96%19.76%21.95%16.88%18.50%20.70%19.50%
Upgrade
Free Cash Flow Margin
10.53%10.21%22.90%17.13%12.89%17.81%16.94%18.96%13.45%11.47%
Upgrade
Effective Tax Rate
25.71%21.75%17.30%18.76%18.29%17.04%36.83%33.66%34.73%33.29%
Upgrade
EBITDA
290297.04240.98174.82225.27216.96205.39192.99196.89160.4
Upgrade
EBITDA Margin
18.49%29.04%25.15%22.16%28.68%30.43%32.29%34.22%36.14%33.81%
Upgrade
Depreciation & Amortization
144.7368.2569.8762.8752.7341.6342.0738.7724.0821.75
Upgrade
EBIT
145.26228.79171.11111.95172.54175.33163.32154.22172.81138.64
Upgrade
EBIT Margin
9.26%22.37%17.86%14.19%21.97%24.59%25.68%27.34%31.72%29.23%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).